| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Satish N Nadig | |
| Kathryn J Wood | |||
| Cherry I Kingsley | |||
| P2860 | cites work | Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 |
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| CTLA-4 can function as a negative regulator of T cell activation | Q28235866 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
| Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. | Q33853487 | ||
| CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
| Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration | Q73565569 | ||
| Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand | Q73585351 | ||
| CD4(+), CD25(+) T cells as regulators of alloimmune responses | Q73667423 | ||
| Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection | Q73667838 | ||
| Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning | Q73910639 | ||
| CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection | Q73948820 | ||
| Regulation of TGF-beta response during T cell activation is modulated by IL-10 | Q74147852 | ||
| Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation | Q74249616 | ||
| T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection | Q74817270 | ||
| The induction of transplantation tolerance by intrathymic (i.t.) delivery of alloantigen: a critical relationship between i.t. deletion, thymic export of new T cells and the timing of transplantation | Q77658966 | ||
| Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope: differential analysis of regulatory cytokines in the lymphoid and intragraft compartments | Q78164664 | ||
| Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism | Q78237930 | ||
| Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy | Q78488897 | ||
| Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex | Q78833880 | ||
| In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance | Q79143624 | ||
| Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning | Q79329006 | ||
| Non-myeloablative mixed chimerism approaches and tolerance, a split decision | Q80052362 | ||
| Combined costimulation blockade prevents rejection of allogeneic islets in mice | Q80256661 | ||
| Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model | Q83978985 | ||
| CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway | Q70897771 | ||
| Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen | Q72051514 | ||
| CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression | Q73098784 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Actively acquired tolerance of foreign cells | Q34233179 | ||
| CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase | Q34356219 | ||
| Late hepatic allograft dysfunction | Q34426400 | ||
| CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates | Q34433847 | ||
| Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 | ||
| Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. | Q34504134 | ||
| Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity | Q34505678 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation | Q34591923 | ||
| "Infectious" transplantation tolerance. | Q34726892 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy | Q35237202 | ||
| Control of immune pathology by regulatory T cells | Q35580406 | ||
| Regulatory cells in transplantation. | Q35580423 | ||
| Heterologous immunity: an overlooked barrier to tolerance | Q35583521 | ||
| Induction of tolerance | Q35712092 | ||
| Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection | Q35939463 | ||
| Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation | Q36104468 | ||
| Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. | Q36350355 | ||
| Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen | Q36355970 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
| Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival | Q36370261 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance | Q36401145 | ||
| Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells | Q36401309 | ||
| A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression | Q36447586 | ||
| Costimulation blockade and its possible future use in clinical transplantation. | Q36570561 | ||
| Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model | Q37174844 | ||
| A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance | Q37388089 | ||
| Mixed allogeneic chimerism as an approach to transplantation tolerance | Q39580661 | ||
| Mesenchymal stem cells and organ transplantation: current status and promising future | Q40321342 | ||
| Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. | Q40459668 | ||
| Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. | Q40794187 | ||
| Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation | Q40970026 | ||
| Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. | Q41326954 | ||
| Total lymphoid irradiation in kidney and liver transplantation in the baboon: prolonged graft survival and alterations in T cell subsets with low cumulative dose regimens | Q41546952 | ||
| Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses. | Q42691510 | ||
| Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection | Q43655794 | ||
| Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation | Q43848079 | ||
| In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation | Q44097232 | ||
| Anti-CD40 therapy extends renal allograft survival in rhesus macaques | Q44190483 | ||
| New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. | Q44200460 | ||
| Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning | Q44210726 | ||
| Programmed death-1 targeting can promote allograft survival | Q44223920 | ||
| Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease | Q44228610 | ||
| Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. | Q44549969 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| CTLA4Ig: bridging the basic immunology with clinical application | Q45234481 | ||
| Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning | Q45883050 | ||
| HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism | Q46397702 | ||
| Costimulation blockade with belatacept in renal transplantation | Q46569880 | ||
| Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways | Q46963324 | ||
| Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen | Q47784478 | ||
| Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. | Q51541351 | ||
| CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. | Q54139898 | ||
| Infectious tolerance. | Q55068093 | ||
| Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression | Q56786693 | ||
| Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
| Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment | Q56904437 | ||
| CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
| Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment | Q56906119 | ||
| Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner | Q56906395 | ||
| Transplantation of anergic histoincompatible bone marrow allografts | Q56906962 | ||
| CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment | Q56907083 | ||
| The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival | Q56907194 | ||
| The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo | Q56907415 | ||
| Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways | Q56908985 | ||
| Stimulating PD-1???negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival1 | Q57202266 | ||
| Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen | Q58194512 | ||
| CD40 ligand-transduced co-stimulation of T cells in the development of helper function | Q58882277 | ||
| Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts | Q59068399 | ||
| IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
| MECHANISMS OF TOLERANCE INDUCTION AFTER INTRATHYMIC ISLET INJECTION | Q60700627 | ||
| Dominant transplantation tolerance impairs CD8+ T cell function but not expansion | Q61651663 | ||
| Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance | Q61651670 | ||
| CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS | Q61651679 | ||
| Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice | Q61791934 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways | Q64038816 | ||
| Treatment of renal-cell cancer by transplantation of allogeneic stem cells. | Q64981713 | ||
| Induction of donor-specific unresponsiveness by intrathymic islet transplantation | Q68354945 | ||
| P433 | issue | 10 | |
| P921 | main subject | immune tolerance | Q1356761 |
| organ transplantation | Q69253852 | ||
| P304 | page(s) | 828-841 | |
| P577 | publication date | 2007-08-17 | |
| 2007-10-01 | |||
| P1433 | published in | Transplant International | Q15762140 |
| P1476 | title | Transplantation tolerance: lessons from experimental rodent models | |
| P478 | volume | 20 |
| Q38922184 | A Novel Model on DST-Induced Transplantation Tolerance by the Transfer of Self-Specific Donor tTregs to a Haplotype-Matched Organ Recipient |
| Q42234521 | BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION. |
| Q38187177 | Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients |
| Q43296293 | CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice |
| Q37794623 | CD4+ regulatory T cells in solid organ transplantation |
| Q46034786 | Clinical rejection and persistent immune regulation in kidney transplant patients. |
| Q37843801 | Clinical transplantation tolerance |
| Q46759811 | Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation. |
| Q26801029 | Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism |
| Q45134145 | Donor specific transplant tolerance is dependent on complement receptors. |
| Q33882845 | Identification of a B cell signature associated with renal transplant tolerance in humans. |
| Q47122472 | Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin |
| Q49962904 | Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. |
| Q37384199 | Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection |
| Q35620293 | Neonatal desensitization for the study of regenerative medicine |
| Q28080994 | Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes |
| Q92511099 | Systemic silencing of PHD2 causes reversible immune regulatory dysfunction |
| Q37607455 | The immunological monitoring of kidney and liver transplants in adult and pediatric recipients |
| Q28478144 | The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response |
| Q38039091 | Translating tolerogenic therapies to the clinic - where do we stand? |
| Q43139370 | Transplantation of tail skin to study allogeneic CD4 T cell responses in mice. |
Search more.